Literature DB >> 30002045

FDG-PET in PMBCL: which heterogeneity?

Michel Meignan1, Anne-Ségolène Cottereau2.   

Abstract

Mesh：

Substances：

Year:  2018        PMID： 30002045     DOI： 10.1182/blood-2018-05-850305

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  3 in total

Review 1.  Current Role of Functional Imaging in the Management of Lymphoma.

Authors:  Bruce D Cheson; Michel Meignan
Journal:  Curr Oncol Rep       Date:  2021-11-04       Impact factor: 5.075

2.  Continuous infusion chemotherapy, radiotherapy, and FDG-PET are feasible during extracorporeal membrane oxygenation.

Authors:  Seth J Rotz; Francisco A Almeida; Shlomo Koyfman; Sudhir Krishnan; Guramrinder Singh Thind; William Phillips; James Yun; Anthony Zembillas; Mark Zahniser; Alejandro Bribriesco
Journal:  Pediatr Blood Cancer       Date:  2020-07-16       Impact factor: 3.167

Review 3.  Biology and therapy of primary mediastinal B-cell lymphoma: current status and future directions.

Authors:  Charlotte Lees; Colm Keane; Maher K Gandhi; Jay Gunawardana
Journal:  Br J Haematol       Date:  2019-02-10       Impact factor: 6.998
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.